The global assisted reproductive technology market was valued at USD 21.32 billion in 2018 and is expected to reach USD 45.06 billion by 2026, growing at a CAGR of 9.8%. The U.S. is experiencing significant market growth, driven by rising infertility rates, advancements in medical technologies, and increased awareness of reproductive treatments. In 2018, Europe led the global market with a share of 41.18%.
Assisted reproductive technologies are treatments used to address infertility, including procedures like in-vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo transfer (FET), and gamete intrafallopian transfer (GIFT). The demand for ART is driven by rising infertility rates due to changing lifestyles, stress, and government initiatives supporting fertility services. Advanced techniques such as ICSI and FET, with strong clinical outcomes, are also fueling market growth. However, high treatment costs and socio-ethical concerns, especially in emerging countries, limit the widespread adoption of ART. According to the WHO, many women in these regions cannot afford such treatments.
Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/assisted-reproductive-technology-art-market-101811
Assisted Reproductive Technology Market Trends:
The rising prevalence of infertility, particularly in countries like China, the U.S., the U.K., and India, is driving demand for assisted reproductive technologies (ART). In the U.S., 6.7% of women aged 15-44 experienced infertility in 2018, and infertility among men is also on the rise. Factors such as sedentary lifestyles, stress, and obesity contribute to this trend. To address this, governments and non-profit organizations in both developed and emerging countries are working to make fertility treatments more affordable, further boosting market growth.
List Of Top Assisted Reproductive Technology Market Companies:
· Bloom IVF Centre
· California Cryobank
· CARE Fertility
· Monash IVF Group
· Carolinas Fertility Institute
· European Sperm Bank
· INVO Bioscience
· Apollo Hospitals Enterprise Ltd.
· Other Players
Assisted Reproductive Technology Market Segmentation:
By Technique Outlook
In vitro fertilization (IVF) dominated the ART market in 2018, thanks to its high success rate and ongoing advancements, such as time-lapse imaging systems to monitor egg division. These innovations are expected to drive further adoption of IVF. Frozen embryo transfer (FET) holds the second-largest market share, offering a cost-effective option with a high success rate and faster results compared to fresh IVF cycles. Other techniques, like gamete intrafallopian transfer (GIFT) and zygote intrafallopian transfer (ZIFT), are also gaining popularity due to their proven effectiveness.
By Procedure Outlook
The fresh non-donor procedure is projected to grow at the highest CAGR, driven by its high success rate and the increasing prevalence of infertility. Studies show a 19% live birth rate for fresh egg-based fertility cycles. The frozen non-donor procedure, which is more affordable, holds the second-largest share, while fresh donor and frozen donor procedures are also expected to see significant growth.
By End-User Outlook
Fertility clinics dominated the ART market in 2018 and are expected to maintain this position due to the growing number of specialized procedures and doctors in these settings. The segment is projected to grow faster, particularly in emerging countries like China, Japan, and India. In contrast, hospitals accounted for a smaller share of the market, with slower growth due to less adoption of advanced techniques and inadequate patient services.
Assisted Reproductive Technology Market Regional Analysis:
Europe led the ART market in 2018 with a revenue of USD 8.78 billion and is expected to remain dominant due to the high demand for ART procedures, especially in countries like Spain, Denmark, the U.K., Germany, and France. North America is projected to register significant growth, driven by the increasing adoption of fertility services and high disposable income in the U.S. The Asia Pacific region is expected to experience the highest growth rate by 2026, fueled by the rising prevalence of infertility and reduced socio-ethical stigma, particularly in countries like India, China, Australia, and Japan. Latin America and the Middle East & Africa are also expected to grow moderately, supported by improving healthcare infrastructure and increasing infertility rates.
Key Industry Development:
In April 2019, Silverfleet Capital Partners acquired a significant stake in CARE Fertility to diversify its product portfolio and enhance its market position.